Parkinson’s disease is the second most common incurable neurodegenerative disorder after Alzheimer’s disease.
It is characterised by the accumulation of protein deposits in dopaminergic neurons (in charge of producing dopamine) in the form of amyloid fibres. These aggregates are formed mainly by the alpha-synuclein protein and in a very complex manner, which makes it complicated to identify molecules which could prevent or revert the process and the neurodegeneration associated with it.
A scientific collaboration led by researchers at the Institute of Biotechnology and Biomedicine (IBB) of the Universitat Autònoma de Barcelona has identified a molecule which halts and reverts this neurodegeneration. After analysing over 14,000 molecules, they found the SynuClean-D molecule, which inhibits the aggregation of the alpha-synuclein protein and breaks the already formed amyloid fibres, thus preventing the initiation of the process causing the onset of the neurodegenerative Parkinson’s disease.
Through experiments conducted with the small Caenorhabditis elegans worm, one of the most commonly used animal models in neurodegenerative diseases, researchers were able to verify that by administering it through food, the molecule was capable of notably reducing alpha-synuclein aggregations, preventing the spread of toxic aggregates and therefore avoiding the degeneration of dopaminergic neurons.
“Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative disases such as Parkinson’s in the future”, UAB researcher and coordinator of the study Salvador Ventura points out.
To identify SynuClean-D researchers developed a methodology capable of indentifying the alpha-synuclein aggregation inhibitors among thousands of molecules. Once identified, an in vitro biophysical characterisation was conducted of their inhibiting activity and tests were run to discover their behaviour with human neural cell cultures, before testing it in animal models of the disease (the Caenorhabditis elegans worm). These animals express the alpha-synuclein in the muscle or in dopaminergic neurons. The experiments demonstrated that the administration of the identified inhibitor reduced protein aggregation, improving the mobility of the animal and protecting it from neural degeneration.
Learn more: Molecule capable of halting and reverting neurodegeneration caused by Parkinson’s disease identified
The Latest on: Parkinson’s
[google_news title=”” keyword=”Parkinson’s” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Parkinson’s
- Ozzy Osbourne Opens Up About His Stem Cell Treatment for Parkinson’s Diseaseon May 1, 2024 at 10:28 am
Ozzy offered an update on his health on his SiriusXM program with Billy Morrison. Ozzy Osbourne Opens Up About His Stem Cell Treatment for Parkinson’s Disease Jon Hadusek ...
- Who is Cecil Parkinson and what happened to Sara Keays?on May 1, 2024 at 8:29 am
Once tipped to be a future Prime Minister, Lord Parkinson's political career was derailed by a shocking sex scandal involving his long-time secretary Sara Keays ...
- 4 friends with Parkinson's disease cycling across the country to raise money for researchon May 1, 2024 at 7:57 am
CHICAGO (CBS) --Four friends will set off on a journey of a lifetime on Wednesday, cycling across America while raising money for two Parkinson's disease foundations. The Chicago-area organizer is ...
- Study links agricultural pesticide exposure to increased genetic variants in Parkinson’s diseaseon May 1, 2024 at 5:04 am
Recent research has highlighted the role of autophagic function in PD etiology, with mutations in the glucosylceramidase beta (GBA1) gene increasing the likelihood of developing PD. In the present ...
- Living your best life after a Parkinson’s diagnosison April 30, 2024 at 10:00 pm
Parkinson’s disease is a neurodegenerative disorder that progressively affects movement, leading to significant physical and neurological challenges. While symptoms and disease progression are unique ...
- Pedaling for Parkinson’son April 30, 2024 at 7:00 pm
SALT LAKE CITY, Utah (Ivanhoe Newswire) – Nearly one million people in the U.S. are living with Parkinson’s disease. There is no cure and symptoms only get worse. But a new program – backed by ...
- She had Parkinson's and didn't want to live. Then she got this surgery.on April 30, 2024 at 10:29 am
Deep brain stimulation is a game-changer for patients like Peters amid the ongoing fight for medical breakthroughs for neurologic conditions.
- Researchers target neurogenesis in new approach to treat Parkinson's diseaseon April 30, 2024 at 8:05 am
Researchers at the University of Toronto have found a way to better control the preclinical generation of key neurons depleted in Parkinson's disease, pointing toward a new approach for a disease with ...
- Community members get moving to raise awareness and money for Parkinson'son April 29, 2024 at 1:18 pm
Sunday's weather was perfect for going outside, and an organization helped make it into a day to raise awareness for a condition that affects hundreds of thousa ...
via Bing News